Outlook Therapeutics, Inc. Common Stock (OTLK) is a publicly traded Healthcare sector company. As of September 2, 2026, OTLK trades at $0.63 with a market cap of $151.21M and a P/E ratio of -0.35. OTLK moved +1.01% today. Year to date, OTLK is -5.11%; over the trailing twelve months it is -29.63%. Its 52-week range spans $0.16 to $3.39. Analyst consensus is buy with an average price target of $5.20. Rallies surfaces OTLK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for OTLK shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.63 |
| Market Cap | $151.21M |
| P/E Ratio | -0.35 |
| EPS | $-1.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.39 |
| 52-Week Low | $0.16 |
| Volume | 4.47M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.41M |
| Net Income | $-62.42M |
| Gross Margin | 4.05% |
3 analysts cover OTLK: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.20.